Budde K - Search Results

1

Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.

Salvadori M, Bertoni E, Budde K, Holzer H, Civati G, Lien B, Arns W. Salvadori M, et al. Among authors: budde k. Transplant Proc. 2010 May;42(4):1325-8. doi: 10.1016/j.transproceed.2010.03.044. Transplant Proc. 2010. PMID: 20534293

2

Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.

Nashan B, Suwelack B, Ivens K, Arns W, Lhotta K, Bourbigot B, Budde K, Fischer W, Pietruck F; ERL2405-DE02 Study Group. Nashan B, et al. Among authors: budde k. Transplant Proc. 2006 Nov;38(9):2856-9. doi: 10.1016/j.transproceed.2006.08.118. Transplant Proc. 2006. PMID: 17112848 Clinical Trial.

3

Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

Reinke P, Budde K, Hugo C, Petersen P, Schnuelle P, Fricke L, Scholz D, Sperschneider H, Bahner U, Kramer S, Fischer W, Arns W. Reinke P, et al. Among authors: budde k. Transplant Proc. 2011 Jun;43(5):1641-6. doi: 10.1016/j.transproceed.2011.01.184. Transplant Proc. 2011. PMID: 21693250

4

FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.

Salvadori M, Budde K, Charpentier B, Klempnauer J, Nashan B, Pallardo LM, Eris J, Schena FP, Eisenberger U, Rostaing L, Hmissi A, Aradhye S; FTY720 0124 Study Group. Salvadori M, et al. Among authors: budde k. Am J Transplant. 2006 Dec;6(12):2912-21. doi: 10.1111/j.1600-6143.2006.01552.x. Am J Transplant. 2006. PMID: 17061999 Free article. Clinical Trial.

5

Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.

Heller T, van Gelder T, Budde K, de Fijter JW, Kuypers D, Arns W, Schmidt J, Rostaing L, Powis SH, Claesson K, Macphee IA, Pohanka E, Engelmayer J, Brandhorst G, Oellerich M, Armstrong VW. Heller T, et al. Among authors: budde k. Am J Transplant. 2007 Jul;7(7):1822-31. doi: 10.1111/j.1600-6143.2007.01859.x. Epub 2007 May 26. Am J Transplant. 2007. PMID: 17532750 Free article. Clinical Trial.

6

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Budde K, Knoll G, Curtis J, Kahana L, Pohanka E, Seifu Y, Neumayer HH. Budde K, et al. Transplant Proc. 2005 Mar;37(2):912-5. doi: 10.1016/j.transproceed.2004.12.048. Transplant Proc. 2005. PMID: 15848573 Clinical Trial.

7

Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies.

Legendre C, Cohen D, Zeier M, Rostaing L, Budde K. Legendre C, et al. Among authors: budde k. Transplant Proc. 2007 Jun;39(5):1386-91. doi: 10.1016/j.transproceed.2007.03.064. Transplant Proc. 2007. PMID: 17580145

8

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing KM, Abrams K, Witte S, Woodle ES. Friman S, et al. Among authors: budde k. Am J Transplant. 2011 Jul;11(7):1444-55. doi: 10.1111/j.1600-6143.2011.03538.x. Epub 2011 May 12. Am J Transplant. 2011. PMID: 21564523 Free article. Clinical Trial.

9

Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.

Budde K, Lehner F, Sommerer C, Arns W, Reinke P, Eisenberger U, Wüthrich RP, Scheidl S, May C, Paulus EM, Mühlfeld A, Wolters HH, Pressmar K, Stahl R, Witzke O; ZEUS Study Investigators. Budde K, et al. Am J Transplant. 2012 Jun;12(6):1528-40. doi: 10.1111/j.1600-6143.2012.03994.x. Epub 2012 Mar 5. Am J Transplant. 2012. PMID: 22642473 Free article. Clinical Trial.

10

Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study.

Budde K, Lehner F, Sommerer C, Reinke P, Arns W, Eisenberger U, Wüthrich RP, Mühlfeld A, Heller K, Porstner M, Veit J, Paulus EM, Witzke O; ZEUS Study Investigators. Budde K, et al. Am J Transplant. 2015 Jan;15(1):119-28. doi: 10.1111/ajt.12952. Epub 2014 Dec 17. Am J Transplant. 2015. PMID: 25521535 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page